×
Draxxin KP 250 ml
290 USD
Category:
Animal Supplements - Veterinary
Product Description
For the treatment of bovine respiratory disease (BRD) associated with pyrexia due to Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis susceptible to tulathromycin.
Each mL Contains:
|
INGREDIENTS: Each mL of DRAXXIN KP contains 100 mg of tulathromycin as a free base and 120 mg ketoprofen as a free acid in a 50% propylene glycol vehicle.
|
|
INACTIVE INGREDIENTS: monothioglycerol (5 mg/mL), 2-pyrrolidone (70 mg/mL), citric acid (20 mg/mL) and sodium hydroxide/hydrochloric acid added to adjust pH. DRAXXIN KP contains an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio and a racemic mixture of ketoprofen.
|
Dosage & Administration
- A single subcutaneous injection of 2.5 mg tulathromycin/kg bodyweight and 3 mg ketoprofen/kg bodyweight (equivalent to 1 ml/40 kg bodyweight).
- For treatment of cattle over 400 kg bodyweight, divide the dose so that no more than 10 ml are injected at one site.
- To ensure correct dosage bodyweight should be determined as accurately as possible to avoid underdosing.
Withdrawals
Meat and offal: 50 days
Not authorised for use in cattle producing milk for human consumption.
Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition.
Product Species
-
Cattle - Dairy -
Cattle - Beef
290 USD
